02069nam 2200529 450 991082008240332120230803024244.01-78084-234-1(CKB)2560000000152110(EBL)1179656(SSID)ssj0001599984(PQKBManifestationID)16306847(PQKBTitleCode)TC0001599984(PQKBWorkID)14892523(PQKB)10903111(MiAaPQ)EBC1179656(Au-PeEL)EBL1179656(OCoLC)877767290(EXLCZ)99256000000015211020220517d2013 uy 0engur|n|---|||||txtccrNovel approaches in migraine treatment /editor, Hans-Christoph Diener1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (153 p.)Description based upon print version of record.1-78084-236-8 Title page; Copyright page; Contents; Foreword. Novel approaches in migraine treatment; 1. Potential treatment targets and the experience with triptans; 2. Calcitonin gene-related peptide receptor antagonists; 3. Lasmiditan; 4. Microglial modulation in migraine; 5. Transcranial magnetic stimulation for migraine treatment; 6. Patent foramen ovale closure; 7. Biofeedback enhances the migraine threshold; 8. Botulinum toxin for migraine treatment; 9. Sphenopalatine ganglion stimulation in primary headaches; 10. Nutraceuticals in migraine treatment; IndexNovel Approaches in Migraine TreatmentMigraineTreatmentMigrainePreventionMigraineTreatment.MigrainePrevention.616.84912Diener Hans-ChristophMiAaPQMiAaPQMiAaPQBOOK9910820082403321Novel approaches in migraine treatment4017196UNINA